☰

Asen Bagashev, Ph.D. - Publications

Affiliations: 
2014 Cell Biology Temple University, Philadelphia, PA, United States 
Area:
Neuroscience Biology, Molecular Biology, Virology Biology
Tree Info Grants Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Bagashev A, Sotillo E, Tang CA, Black KL, Perazzelli J, Seeholzer SH, Argon Y, Barrett DM, Grupp SA, Hu CA, Thomas-Tikhonenko A. Correction for Bagashev et al., "CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum". Molecular and Cellular Biology. e0032822. PMID 35976030 DOI: 10.1128/mcb.00328-22  0.605
2022 Shrestha J, Santerre M, Allen CNS, Arjona SP, Merali C, Mukerjee R, Chitrala KN, Park J, Bagashev A, Bui V, Eugenin EA, Merali S, Kaul M, Chin J, Sawaya BE. HIV-1 gp120 Impairs Spatial Memory Through Cyclic AMP Response Element-Binding Protein. Frontiers in Aging Neuroscience. 14: 811481. PMID 35615594 DOI: 10.3389/fnagi.2022.811481  0.606
2021 Zheng S, Gillespie E, Naqvi AS, Hayer KE, Ang Z, Torres-Diz M, Quesnel-Vallières M, Hottman DA, Bagashev A, Chukinas J, Schmidt C, Asnani M, Shraim R, Taylor DM, Rheingold SR, et al. Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies. Blood Cancer Discovery. PMID 35015683 DOI: 10.1158/2643-3230.BCD-21-0087  0.759
2020 Ross S, Bagashev A, Schneider D, Hu P, Tasian S, Fry T. Abstract 3234: Multi-antigen targeting of CD19, CD22 and TSLPR to prevent Ph-like ALL resistance Immunology. 80: 3234-3234. DOI: 10.1158/1538-7445.Am2020-3234  0.421
2019 Pillai V, Muralidharan K, Meng W, Bagashev A, Oldridge DA, Rosenthal J, Van Arnam J, Melenhorst JJ, Mohan D, DiNofia AM, Luo M, Cherian S, Fromm JR, Wertheim G, Thomas-Tikhonenko A, et al. CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy. Blood Advances. 3: 3539-3549. PMID 31738832 DOI: 10.1182/Bloodadvances.2019000692  0.653
2019 Asnani M, Hayer KE, Naqvi AS, Zheng S, Yang SY, Oldridge D, Ibrahim F, Maragkakis M, Gazzara MR, Black KL, Bagashev A, Taylor D, Mourelatos Z, Grupp SA, Barrett D, et al. Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19. Leukemia. PMID 31591467 DOI: 10.1038/S41375-019-0580-Z  0.737
2018 Santerre M, Bagashev A, Gorecki L, Lysek KZ, Wang Y, Shrestha J, Del Carpio-Cano F, Mukerjee R, Sawaya BE. HIV-1 Tat protein promotes neuronal dysregulation by inhibiting E2F transcription factor 3 (E2F3). The Journal of Biological Chemistry. PMID 30591585 DOI: 10.1074/Jbc.Ra118.003744  0.654
2018 Black KL, Naqvi AS, Asnani M, Hayer KE, Yang SY, Gillespie E, Bagashev A, Pillai V, Tasian SK, Gazzara MR, Carroll M, Taylor D, Lynch KW, Barash Y, Thomas-Tikhonenko A. Aberrant splicing in B-cell acute lymphoblastic leukemia. Nucleic Acids Research. PMID 30517739 DOI: 10.1093/nar/gky1231  0.723
2018 Black KL, Naqvi AS, Asnani M, Hayer KE, Yang SY, Gillespie E, Bagashev A, Pillai V, Tasian SK, Gazzara MR, Carroll M, Taylor D, Lynch KW, Barash Y, Thomas-Tikhonenko A. Aberrant splicing in B-cell acute lymphoblastic leukemia. Nucleic Acids Research. PMID 30357359 DOI: 10.1093/Nar/Gky946  0.728
2018 Bagashev A, Sotillo E, Tang CA, Black KL, Perazzelli J, Seeholzer SH, Argon Y, Barrett DM, Grupp SA, Hu CA, Thomas-Tikhonenko A. CD19 alterations emerging after CD19-directed immunotherapy cause retention of the misfolded protein in the endoplasmic reticulum. Molecular and Cellular Biology. PMID 30104252 DOI: 10.1128/Mcb.00383-18  0.663
2015 Sotillo E, Barrett DM, Black KL, Bagashev A, Oldridge D, Wu G, Sussman R, Lanauze C, Ruella M, Gazzara MR, Martinez NM, Harrington CT, Chung EY, Perazzelli J, Hofmann TJ, et al. Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy. Cancer Discovery. PMID 26516065 DOI: 10.1158/2159-8290.Cd-15-1020  0.678
2015 Bagashev A, Sotillo E, Wu G, Thomas-Tikhonenko A. The Importance of CD19 Exon 2 for Surface Localization: Closing the Ig-like Loop Blood. 126: 3433-3433. DOI: 10.1182/Blood.V126.23.3433.3433  0.663
2014 Bagashev A, Mukerjee R, Santerre M, Del Carpio-Cano FE, Shrestha J, Wang Y, He JJ, Sawaya BE. Involvement of miR-196a in HIV-associated neurocognitive disorders. Apoptosis : An International Journal On Programmed Cell Death. 19: 1202-14. PMID 24872081 DOI: 10.1007/S10495-014-1003-2  0.649
2014 Bagashev A, Mukerjee R, Shrestha J, Santerre M, Wang Y, Sawaya BE. HIV-1 Tat promotes premature brain aging Bmc Infectious Diseases. 14. DOI: 10.1186/1471-2334-14-S2-P63  0.617
2013 Bagashev A, Sawaya BE. Roles and functions of HIV-1 Tat protein in the CNS: an overview. Virology Journal. 10: 358. PMID 24359561 DOI: 10.1186/1743-422X-10-358  0.649
2013 Bagashev A, Fan S, Mukerjee R, Claudio PP, Chabrashvili T, Leng RP, Benchimol S, Sawaya BE. Cdk9 phosphorylates Pirh2 protein and prevents degradation of p53 protein. Cell Cycle (Georgetown, Tex.). 12: 1569-77. PMID 23603988 DOI: 10.4161/Cc.24733  0.631
2013 Mukerjee R, Chang JR, Del Valle L, Bagashev A, Gayed MM, Lyde RB, Hawkins BJ, Brailoiu E, Cohen E, Power C, Azizi SA, Gelman BB, Sawaya BE. Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. Journal of Biological Chemistry. 288: 28310-28310. DOI: 10.1074/Jbc.A113.241547  0.635
2013 Chang JR, Mukerjee R, Bagashev A, Valle LD, Chabrashvili T, Hawkins BJ, He JJ, Sawaya BE. Erratum: HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs (Journal of Biological Chemistry (2011) 286 (41125-41134) DOI:10.1074/jbc.A111.268466) Journal of Biological Chemistry. 288. DOI: 10.1074/Jbc.A111.268466  0.645
2013 Mukerjee R, Chang JR, Valle LD, Bagashev A, Gayed MM, Lyde RB, Hawkins BJ, Brailoiu E, Cohen E, Power C, Azizi SA, Gelman BB, Sawaya BE. Erratum: Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders (Journal of Biological Chemistry (2011) 286 (34976-34985) DOI:10.1074/jbc.A111.241547) Journal of Biological Chemistry. 288. DOI: 10.1074/Jbc.A111.241547  0.634
2013 Bagashev A, Fan S, Mukerjee R, Claudio PP, Chabrashvili T, Leng RP, Benchimol S, Sawaya BE. Cdk9 phosphorylates Pirh2 protein and prevents degradation of p53 protein Veterinary Record. 172: 1569-1577.  0.554
2012 Chang JR, Ghafouri M, Mukerjee R, Bagashev A, Chabrashvili T, Sawaya BE. Role of p53 in neurodegenerative diseases. Neuro-Degenerative Diseases. 9: 68-80. PMID 22042001 DOI: 10.1159/000329999  0.574
2011 Chang JR, Mukerjee R, Bagashev A, Del Valle L, Chabrashvili T, Hawkins BJ, He JJ, Sawaya BE. HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. The Journal of Biological Chemistry. 286: 41125-34. PMID 21956116 DOI: 10.1074/Jbc.M111.268466  0.631
2011 Mukerjee R, Chang JR, Del Valle L, Bagashev A, Gayed MM, Lyde RB, Hawkins BJ, Brailoiu E, Cohen E, Power C, Azizi SA, Gelman BB, Sawaya BE. Deregulation of microRNAs by HIV-1 Vpr protein leads to the development of neurocognitive disorders. The Journal of Biological Chemistry. 286: 34976-85. PMID 21816823 DOI: 10.1074/Jbc.M111.241547  0.66
2011 Mukerjee R, Chang JR, Del Valle L, Bagashev A, Gayed MM, Lyde RB, Hawkins BJ, Cohen E, Power C, Azizi SA, Sawaya BE. Deregulation of microRNAs by HIV-1 Vpr leads to the development of neurocognitive disorders Retrovirology. 8. DOI: 10.1186/1742-4690-8-S2-P51  0.656
Show low-probability matches.